MRC Contribution to a CR-UK and EPSRC Cancer Imaging Initiative
Lead Research Organisation:
Cancer Research UK
Department Name: UNLISTED
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Technical Summary
The Medical Research Council (MRC) is investing #3 million in a nationwide initiative to improve the detection, diagnosis and treatment of cancer. The #50 million initiative, in partnership with Cancer Research UK (CRUK), the Engineering Physical Sciences Research Council and the National Institute for Health Research, will help experts develop new techniques and uses for existing cancer imaging technologies. The MRCs investment is part of the organisations broader, long-term plans to inject funds into imaging and translational research and will help put the UK on track to lead the world in imaging research|
People |
ORCID iD |
Publications
Chalmers KH
(2010)
Design principles and theory of paramagnetic fluorine-labelled lanthanide complexes as probes for (19)F magnetic resonance: a proof-of-concept study.
in Chemistry (Weinheim an der Bergstrasse, Germany)
Chalmers KH
(2011)
Strategies to enhance signal intensity with paramagnetic fluorine-labelled lanthanide complexes as probes for 19F magnetic resonance.
in Dalton transactions (Cambridge, England : 2003)
Chalmers KH
(2011)
19F-lanthanide complexes with increased sensitivity for 19F-MRI: optimization of the MR acquisition.
in Magnetic resonance in medicine
Figg WD
(2014)
Pharmacologic biomarkers in the development of stratified cancer medicine.
in Clinical cancer research : an official journal of the American Association for Cancer Research
Yan Ran
(2008)
The first preparation of all regioisomers of ethyl [
18f]fluorobenzoates
in JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
Yan Ran
(2009)
THE FIRST SYNTHESIS OF ETHYL 3-[
18F]FLUOROBENZOATE USING [
18F]FLUORIDE
in JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
Yan Ran
(2009)
THE FIRST SINGLE-STEP-SINGLE-POST SYNTHESIS OF 4-[
18F]SFB
in JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
| Description | MRC CASE PhD Studentship |
| Amount | £120,000 (GBP) |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 10/2008 |
| End | 09/2012 |
| Description | MRC Dementia Platform |
| Amount | £2,000,000 (GBP) |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 04/2016 |
| End | 11/2016 |
| Description | Univeristy of Durham |
| Organisation | University of Bath |
| Department | Department of Chemistry |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Joint grantee on Programme |
| Collaborator Contribution | Joint grantee |
| Impact | See publications |
| Start Year | 2008 |
| Description | Interaction with pharma and biotech |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Contacts with numerous pharma and boitech employees Clinical trials on novel agents with imaging endpoints brought to Newcastle |
| Year(s) Of Engagement Activity | 2009,2010,2011,2012,2013,2014 |